Distinct Architecture of Lymphatic Vessels Induced by Chimeric Vascular Endothelial Growth Factor-C/Vascular Endothelial Growth Factor Heparin-Binding Domain Fusion Proteins
- 25 May 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 100 (10) , 1468-1475
- https://doi.org/10.1161/01.res.0000269043.51272.6d
Abstract
Vascular endothelial growth factor (VEGF)-C and VEGF-D are composed of the receptor-binding VEGF homology domain and a carboxy-terminal silk homology domain that requires proteolytic cleavage for g...Keywords
This publication has 42 references indexed in Scilit:
- Lymphangiogenesis in development and human diseaseNature, 2005
- The biology of VEGF and its receptorsNature Medicine, 2003
- VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedemaJournal of Clinical Investigation, 2003
- Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3Nature Medicine, 2001
- Mechanisms of angiogenesis and arteriogenesisNature Medicine, 2000
- Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)Proceedings of the National Academy of Sciences, 1998
- VEGF and VEGF-C: Specific Induction of Angiogenesis and Lymphangiogenesis in the Differentiated Avian Chorioallantoic MembraneDevelopmental Biology, 1997
- Hyperplasia of Lymphatic Vessels in VEGF-C Transgenic MiceScience, 1997
- VEGF145, a Secreted Vascular Endothelial Growth Factor Isoform That Binds to Extracellular MatrixJournal of Biological Chemistry, 1997
- Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4.Proceedings of the National Academy of Sciences, 1996